Effects on physiologic measures of appetite from intragastric balloon and endoscopic sleeve gastroplasty: results of a prospective study

Background:Endoscopic bariatric therapies can help address widening management gaps in obesity. Their ability to facilitate weight loss is largely tied to influences on appetite through perturbations of gastric emptying and accommodation. As these tools gain traction in obesity therapy, their physiologic underpinnings require exploration, which may enhance efficacy, tolerance, and patient-tailored care.Methods:We prospectively assessed consecutive subjects with fluid-filled intragastric balloons (IGBs) (n = 18) placed between October 2016 and June 2017 or underwent endoscopic sleeve gastroplasty (ESG) (n = 23) from March 2018 to June 2018. Patients underwent physiologic appraisal at 3 months with ¹³C-spirulina-based gastric emptying breath test to determine time to half emptying (T50), as well as maximum tolerated volume (MTV) of a standard nutrient drink test. Changes in T50 and MTV at 3 months were compared with percent total body weight loss (%TBWL) at 3 and 6 months using best-fit linear regression.Results:The change in T50 at 3 months correlated with %TBWL at 3 months for IGB (P = 0.01) and ESG (P = 0.01) but with greater impact on %TBWL in IGB compared to ESG (R² = 0.42 vs. 0.26). Change in T50 at 3 months was predictive of weight loss at 6 months for IGB (P = 0.01) but not ESG (P = 0.11). ESG was associated with greater decrease in MTV compared to IGB (340.25 ± 297.97 mL vs. 183.00 ± 217.13 mL, P = 0.08), indicting an enhanced effect on satiation through decreased gastric accommodation. Changes in MTV at 3 months did not correlate with %TBWL for either IGB (P = 0.26) or ESG (P = 0.49) but trended toward significance for predicting %TBWL at 6 months for ESG (P = 0.06) but not IGB (P = 0.19).Conclusion:IGB and ESG both induce weight loss but likely through distinct gastric motor function phenotypes, and gastric emptying may predict future weight loss in patients with IGB.     

IABP救治心脏手术后低心排血量的疗效观察

目的：评价主动脉内球囊反捕（ＩＡＢＰ）在心脏手术后不许治低心排血量（低心排）的效果。方法：２８例术后应用中等剂量心脏活性药物支持不能改善的低心排患,均立即使用ＫＡＡＴⅡＰｌｕｓ ＩＡＢＰ（４０ｍｌ）。监 桡动脉和主动脉压力波形,持续监测左心功能,记录尿量,观察末梢循环状况。结果：全组患ＩＡＢＰ辅助时间为（４８±３２）ｈ,早期生存率为７５．０％。所有患在应用ＩＡＢＰ后,桡动脉压力（基础收缩压）     

Underlying mechanisms of saphenous vein graft stenosis after coronary artery bypass caused by clipping of the side branches: an experimental study

BackgroundSaphenous veins are regular bypass conduits selected in non-left anterior descending artery (LAD) coronary artery bypass graft (CABG) surgery. Despite the technical errors, acute thrombosis, intimal hyperplasia and arteriosclerosis which could lead to saphenous vein graft (SVG) failure, the metal-clipping-related SVG failure is unique and rare. This study was conducted to investigate the clinical and underlying mechanisms of the metal-clipping-related SVG failure.MethodsWe collected 6 typical cases of the metal-clipping-related SVG failure in 41 patients who were diagnosed graft stenosis by coronary angiograph after CABG in the Department of Cardiology, Beijing Anzhen Hospital, from January 2020 to September 2021. Furthermore, we built an in vitro model to verify the identical intravascular ultrasound (IVUS) pattern of metal clip.ResultsThere were 6 in 41 cases of SVG stenosis caused by clipping of the side branches. We found that the stenosis of SVG caused by metal clipping mostly occurred at the corner and multipole clipping points. In this situation, great resistance could be felt when pushing the instruments through the stenosis and crystallized cholesterol was rarely caught by the distal protection device. We verified the similar IVUS pattern of metal clip at the side-branches of SVG in vitro.ConclusionsThe metal-clipping-related stenosis may lead to SVG failure. The stenosis of SVG caused by metal clipping mostly occurred at the corner and multipole clipping points. IVUS showed great modality for clarification.     

应用冠脉技术成功治疗重度肺动脉瓣狭窄一例

我国于20世纪80年代中期开展经皮球囊肺动脉瓣成形术(PBPV)技术,现已成为治疗先天性肺动脉瓣狭窄(PS)的首选方法。但对于重度狭窄瓣口面积极小的婴幼儿,常规的球     

A RE I NTERFACILITY G ROUND T RANSPORTS OF P ATIENTS U TILIZING I NTRA - AORTIC B ALLOON P UMPS S AFE ?

Objective. To determine whether the interfacility ground transport of patients with intra-aortic balloon pumps results in morbidity or mortality during transfer. Methods. Charts of all intra-aortic balloon pump transports by a private ambulance company occurring from January 1998 through December 1999 (24 months) were reviewed retrospectively. Records were assessed by a single reviewer for adverse events, explicitly defined as any notation on the record describing death, chest pain, dyspnea, altered mental status, device malfunction, bleeding, unstable vital signs (heart rate <50 beats/min or ≥120 beats/min, respiratory rate <12 breaths/min or ≥30 breaths/min, systolic blood pressure <90?mm?Hg), or hypoxia (oxygen saturation <93%). Unstable vital signs as defined above did not count as adverse events if they represented a patient's baseline condition prior to transport. Results. Thirty-two transports were identified during the study period. Twenty-seven patients (84.4%) had no adverse events. There were no mortalities. Adverse events, none of which resulted in morbidity, were: 1) chest pain and transient paroxysmal atrial tachycardia (relieved with increasing the nitroglycerin infusion); 2) continuous mild chest pain (began during transport and diminished with giving sublingual nitroglycerin and increasing the nitroglycerin infusion); 3) dyspnea and hypoxia (relieved with increased oxygen); 4) transient hypotension (spontaneously resolved); 5) hypotension (resolved by increasing the dopamine infusion). Conclusion. Although a few adverse events occurred, interfacility ground transport of patients with intra-aortic balloon pumps was not associated with morbidity or mortality in this study.     

Comparison of laparoscopic and retroperitoneoscopic approaches to the great vessels in a porcine model

Summary

Conventional laparoscopy has not yet been widely adopted for procedures involving the retroperitoneal organs, due to the problems of adequate bowel retraction and the poor access afforded by the position of the root of the mesentery. Developments in retroperitoneal laparoscopy facilitated by balloon dissection have afforded a new minimally invasive approach to the retroperito-neum. We have compared retroperitoneoscopic and laparoscopic approaches to the great vessels in a porcine model.     

Anatomy of coarctation,hypoplastic and interrupted aortic arch: relevance to interventional/surgical treatment

Obstructive lesions in the aortic arch are comprised of discrete coarctation, tubular hypoplasia and interruption. This review discusses the anatomy of the lesions relevant to interventional treatment. Catheter intervention, using not only balloon angioplasty but also stent implantation for coarctation, has been developed over the past couple of decades as an alternative treatment to surgery. Several studies have reported long-term outcome and the benefits of surgery and catheter intervention for treating obstructive lesions in the aortic arch but more studies are needed for comparable evaluations. The development of imaging and further improvement of surgical and catheter intervention, such as hybrid intervention or new devices, will help in removing the obstruction safely.     

The valve patient and pregnancy

Pregnancy causes a significant and sustained increase in cardiac output that may be poorly tolerated in cases of underlying heart disease. Valvular stenosis is often poorly tolerated and may require intervention during pregnancy, percutaneous intervention being the favored option. Conversely, regurgitant valve diseases are generally well-tolerated. Pregnancy in patients who have previously undergone prosthetic valve replacement raises specific problems linked to anticoagulant therapy. The choice is difficult between oral anticoagulation, which carries a risk of embryopathy, and heparin therapy, which is safer for the fetus but is associated with a high thromboembolic risk for the mother. The diversity of cases highlights the need for appropriate evaluation of heart disease before pregnancy and close follow-up by specialized teams.     

Candida albicans colonization on an intragastric balloon

Here we present the case of Candida albicans colonization on an intragastric balloon placed for weight loss. A 52‐year‐old obese woman achieved a BMI reduction of 10.9 kg/m² within 7 months as a result of a BioEnterics Intragastric Balloon and a well‐balanced, low‐calorie diet. During endoscopy for balloon removal, the balloon, which was well impacted in the gastric fundus, was found to be lime green in color with clusters of cone‐shaped cultures on its surface. Microbiology assessment revealed the presence of Candida albicans, although the patient was totally asymptomatic.     

主动脉内球囊反搏在小儿中的应用

主动脉内球囊反搏(intraaortic balloon pump，IABP)已广泛应用于成年人心源性休克和围手术期低心排血量综合征的治疗，并取得良好的治疗效果，但在小儿中的应用仍较局限。现就有关IABP在小儿中的应用进行综述，着重分析IABP的适应证和影响在小儿中应用的技术困难和其他因素，介绍小儿IABP应用的技术要点，可能的并发症和治疗效果。在无体外膜式氧合器(ECMO)和左心辅助设备的情况下，小儿心脏直视手术后如不能脱离体外循环机或发生严重低心排血量综合征等，应用IABP治疗可收到较好的效果。